Related Experiment Video
Updated: Apr 1, 2026

05:39
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
1.3K
Autophagy and radiosensitization in cancer
Khushboo Sharma1, Rachel Goehe2, Jason M Beckta3
1Virginia Commonwealth University, Departments of Pharmacology and Toxicology.
EXCLI Journal
|September 30, 2015
Summary
Autophagy, a cellular process, plays a dual role in cancer treatment. Understanding its complex response to radiation is key to improving cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Autophagy is a cellular degradation process crucial for maintaining cell homeostasis.
- Its role in cancer is complex, acting as both a pro-survival and pro-death mechanism.
- Radiation therapy frequently induces autophagy in tumor cells, with variable outcomes.
Purpose of the Study:
- To review the multifaceted roles of autophagy in response to radiation therapy.
- To explore these roles across lung cancer, breast cancer, and glioblastoma models.
- To inform strategies for optimizing radiation therapy efficacy.
Main Methods:
- Literature review focusing on autophagy and radiation in cancer.
- Analysis of studies examining autophagy's cytoprotective and cytotoxic effects.
- Comparative assessment across different cancer types (lung, breast, glioblastoma).
Main Results:
- Radiation consistently induces autophagy in tumor cells.
- Radiation-induced autophagy can be cytoprotective, promoting tumor cell survival.
- Conversely, radiation-induced autophagy can also sensitize cells to radiation, mediating cell death.
- The specific role is context-dependent on tumor type and treatment conditions.
Conclusions:
- Autophagy's role in radiation therapy is complex and context-dependent.
- Targeting autophagy could enhance radiation therapy effectiveness.
- Developing strategies to modulate autophagy is crucial for improving cancer treatment outcomes.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells
4.3K
4.3K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Autophagy
6.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.1K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

